VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Precision Oncology for Hepatocellular Cancer: Slivering the Liver by FGF19-FGF4-KLB Pathway Inhibition.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Precision Oncology for Hepatocellular Cancer: Slivering the Liver by FGF19-FGF4-KLB Pathway Inhibition.
Precision Oncology for Hepatocellular Cancer: Slivering the Liver by FGF19-FGF4-KLB Pathway Inhibition. Cancer Discov. 2019 12; 9(12):1646-1649.
View in:
PubMed
subject areas
Carcinoma, Hepatocellular
Fibroblast Growth Factor 4
Fibroblast Growth Factors
Humans
Liver Neoplasms
Membrane Proteins
Precision Medicine
Protein Kinase Inhibitors
Receptor, Fibroblast Growth Factor, Type 4
authors with profiles
VIVEK SUBBIAH